Francis Knuettel II

Insider Reports History

Location
205 Newbury St, Suite 204, Framingham, MA
Signature
/s/ Francis Knuettel II
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Francis Knuettel II:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pelthos Therapeutics Inc. CFO, Treas & Secty Common Stock 10K $100K $10.00 Jul 1, 2025 By Camden Capital LLC
Beeline Holdings, Inc. Director Common Stock 40K $96.8K $2.42 Oct 2, 2025 Direct
Pelthos Therapeutics Inc. CFO, Treas & Secty Common Stock 12.8K $14.1K $1.10 Jul 1, 2025 By Lara Knuettel Revocable Trust
Unrivaled Brands, Inc. CEO and President, Director Common Stock 2.45M Jul 1, 2021 Direct
Terra Tech Corp. CEO and President, Director Nonqualified Stock Option 1.5M Jun 7, 2021 Direct
Unrivaled Brands, Inc. CEO and President, Director Stock Options 769K Jul 1, 2021 Direct
Unrivaled Brands, Inc. CEO and President, Director Common Stock 423K Jul 1, 2021 By Trust
Unrivaled Brands, Inc. CEO and President, Director Warrant (Right to Buy) 192K Jul 1, 2021 By Trust
Pelthos Therapeutics Inc. CFO, Treas & Secty Stock Option 145K Jul 2, 2025 Direct
Pelthos Therapeutics Inc. CFO, Treas & Secty Restricted Stock Units 33.5K Jul 2, 2025 Direct
180 Life Sciences Corp. Director Non-Qualified Stock Option (right to buy) 15K Sep 4, 2023 Direct
180 Life Sciences Corp. Director Common Stock 0 $0.19 Sep 4, 2023 Direct
Pelthos Therapeutics Inc. CFO, Treas & Secty Series A Convertible Preferred Stock 0 Jul 1, 2025 Indirect

Insider Reports Filed by Francis Knuettel II

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BLNE Beeline Holdings, Inc. Oct 2, 2025 1 $0 4 Oct 6, 2025 Director
PTHS Pelthos Therapeutics Inc. Jul 2, 2025 2 $0 4 Jul 7, 2025 CFO, Treas & Secty
PTHS Pelthos Therapeutics Inc. Jul 1, 2025 3 $100K 4 Jul 3, 2025 Chief Financial Officer
BLNE Beeline Holdings, Inc. May 14, 2025 0 $0 3 Jun 2, 2025 Director
CHRO Channel Therapeutics Corp Apr 11, 2025 1 $0 4 Apr 15, 2025 CEO, Pres., CFO, Treas & Secty
IVBT Innovation1 Biotech Inc. Nov 1, 2024 0 $0 3 Feb 4, 2025 Chairman and Interim CEO, Director
CHRO Chromocell Therapeutics Corp Sep 12, 2024 2 $5.04K 4 Sep 16, 2024 CEO, Pres., CFO, Treas & Secty
CHRO Chromocell Therapeutics Corp Sep 10, 2024 2 $11K 4 Sep 12, 2024 CEO, Pres., CFO, Treas & Secty
CHRO Chromocell Therapeutics Corp Jun 28, 2024 2 $0 4 Jul 2, 2024 CEO, Pres., CFO Treas & Secty
CHRO Chromocell Therapeutics Corp Jun 14, 2024 2 $0 4 Jun 18, 2024 CEO, Pres., CFO Treas & Secty
CHRO Chromocell Therapeutics Corp Feb 21, 2024 1 $0 4/A Jun 18, 2024 CEO, Pres., CFO Treas & Secty
CHRO Chromocell Therapeutics Corp Feb 21, 2024 1 $0 4 Feb 23, 2024 Interim CEO, CFO Treas & Secty
CHRO Chromocell Therapeutics Corp Feb 15, 2024 0 $0 3/A Jul 2, 2024 CEO, Pres., CFO, Treas & Secty
CHRO Chromocell Therapeutics Corp Feb 15, 2024 0 $0 3 Feb 15, 2024 Interim CEO, CFO, Treas & Sec
ATNF 180 Life Sciences Corp. Sep 4, 2023 1 $0 4 Sep 8, 2023 Director
LGST Semper Paratus Acquisition Corp Jun 7, 2023 0 $0 3 Jun 14, 2023 Chief Financial Officer
OTEC OceanTech Acquisitions I Corp. Mar 13, 2023 0 $0 3 Apr 21, 2023 Chief Financial Officer
ATNF 180 Life Sciences Corp. May 19, 2022 1 $0 4 May 23, 2022 Director
RACY Relativity Acquisition Corp Feb 10, 2022 0 $0 3 Feb 10, 2022 Director
CDT Murphy Canyon Acquisition Corp. Feb 2, 2022 0 $0 3 Feb 11, 2022 Director
ATNF 180 Life Sciences Corp. Aug 4, 2021 1 $0 4 Aug 5, 2021 Director
ATNF 180 Life Sciences Corp. Jul 2, 2021 0 $0 3 Jul 6, 2021 Director
UNRV Unrivaled Brands, Inc. Jun 18, 2021 6 $0 4 Jul 12, 2021 CEO and President, Director
UNRV Unrivaled Brands, Inc. Jun 7, 2021 1 $0 4/A Jul 12, 2021 CEO and President, Director